{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:07:14Z","timestamp":1764662834896,"version":"3.46.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98282","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:03:37Z","timestamp":1764662617000},"source":"Crossref","is-referenced-by-count":0,"title":["Hemorrhagic Events Associated With Direct Oral Anticoagulants: Frequency and Management"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Ztati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oussama","family":"Zaanouny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayoub","family":"Nasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"El Hattaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03287-4","article-title":"Bleeding-related hospitalizations among direct oral anticoagulant users and nonusers in Medicare fee-for-service: variation in prevalence, burden, and characteristics","volume":"42","author":"Bazell CM","year":"2025","unstructured":"Bazell CM, Alston MN, Ganti LG, et al.. Bleeding-related hospitalizations among direct oral anticoagulant users and nonusers in Medicare fee-for-service: variation in prevalence, burden, and characteristics. Adv Ther. 2025, 42:4916-32. 10.1007\/s12325-025-03287-4","journal-title":"Adv Ther"},{"key":"ref2","unstructured":"Management of bleeding accidents and reversal in patients on anticoagulants. (2023). Accessed. September 02, 2025: https:\/\/smaar.ma\/wp-content\/uploads\/2023\/06\/Gestion-des-accidents-hemorragiques-et-de-la-reversion-chez-les-patients-...."},{"key":"ref3","unstructured":"Oral anticoagulants. direct inhibition of coagulation factors (DOACs). (2025). Accessed: September 02, 2025: https:\/\/pharmacomedicale.org\/medicaments\/par-specialites\/item\/anticoagulants-par-voie-orale-inhibition-directe-des-fa...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2450\/2015.0096-15","article-title":"The evolution of anticoagulant therapy","volume":"14","author":"Franchini M","year":"2016","unstructured":"Franchini M, Liumbruno GM, Bonfanti C, Lippi G. The evolution of anticoagulant therapy. Blood Transfus. 2016, 14:175-84. 10.2450\/2015.0096-15","journal-title":"Blood Transfus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.53738\/REVMED.2014.10.439.1562","article-title":"[The role of new oral anticoagulants]","volume":"10","author":"Pierard L","year":"2014","unstructured":"Pierard L, Sprynger M. [The role of new oral anticoagulants]. Rev Med Suisse. 2014, 10:1562-7. 10.53738\/REVMED.2014.10.439.1562","journal-title":"Rev Med Suisse"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.anrea.2016.08.016","article-title":"[Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015]","volume":"2","author":"Albaladejo P","year":"2016","unstructured":"Albaladejo P, Bonhomme F, Normand B, et al.. [Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015]. Anesth Reanim. 2016, 2:414-20. 10.1016\/j.anrea.2016.08.016","journal-title":"Anesth Reanim"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2008.07.036","article-title":"[Management of vitamin K antagonist overdoses, situations at risk of bleeding, and bleeding events in patients treated with vitamin K antagonists in outpatient and inpatient settings: HAS 2008 Recommendations]","volume":"33","author":"Pernod G","year":"2008","unstructured":"Pernod G, Godier A, Gozalo C, Blanchard P, Si\u00e9 P. [Management of vitamin K antagonist overdoses, situations at risk of bleeding, and bleeding events in patients treated with vitamin K antagonists in outpatient and inpatient settings: HAS 2008 Recommendations]. J Mal Vasc. 2008, 33:S70-1. 10.1016\/j.jmv.2008.07.036","journal-title":"J Mal Vasc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2013.04.009","article-title":"Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013","volume":"106","author":"Pernod G","year":"2013","unstructured":"Pernod G, Albaladejo P, Godier A, et al.. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Arch Cardiovasc Dis. 2013, 106:382-93. 10.1016\/j.acvd.2013.04.009","journal-title":"Arch Cardiovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2016.05.008","article-title":"[Direct oral anticoagulant associated bleeding]","volume":"41","author":"Godier A","year":"2016","unstructured":"Godier A, Martin AC, Rosencher N, Susen S. [Direct oral anticoagulant associated bleeding]. J Mal Vasc. 2016, 41:272-8. 10.1016\/j.jmv.2016.05.008","journal-title":"J Mal Vasc"},{"key":"ref10","article-title":"Direct oral anticoagulants","author":"Hainaut P","year":"2016","unstructured":"Hainaut P. Direct oral anticoagulants. Leuven Med. 2016, 253-8.","journal-title":"Leuven Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1857","article-title":"Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study","volume":"350","author":"Abraham NS","year":"2015","unstructured":"Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ. 2015, 350:h1857. 10.1136\/bmj.h1857","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.04.041","article-title":"Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and\/or aspirin in a randomized, double-blind, placebo-controlled trial","volume":"157","author":"Moayyedi P","year":"2019","unstructured":"Moayyedi P, Eikelboom JW, Bosch J, et al.. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and\/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2019, 157:403-12.e5. 10.1053\/j.gastro.2019.04.041","journal-title":"Gastroenterology"},{"key":"ref13","unstructured":"The oral anticoagulants. (2018). Accessed. September 02, 2025: https:\/\/www.has-sante.fr\/jcms\/c_2851086\/fr\/les-anticoagulants-oraux."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415346-hemorrhagic-events-associated-with-direct-oral-anticoagulants-frequency-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:03:40Z","timestamp":1764662620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415346-hemorrhagic-events-associated-with-direct-oral-anticoagulants-frequency-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.98282","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}